Is Protara Therapeutics Inc (TARA) overvalued? · $228.8M cap
Protara Therapeutics Inc (TARA) is a biotechnology company listed on NASDAQ.
This page asks whether Protara Therapeutics Inc (TARA) looks expensive on cached numbers — not a short thesis.
No cached income statement for TARA, so there is no earnings base to call rich or cheap.
TARA currently screens at market cap $228.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TARA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TARA stock page for the full model, not this heading.
Not investment advice.